Concurrent Management of a Patient with Toxic Epidermal Necrolysis and Coronavirus Disease-19: A Case Presentation

Toxic epidermal necrolysis (TEN) is a serious cutaneous adverse reaction with high mortality rate. The severe acute respiratory syndrome-coronavirus-2 virus disease represented a global pandemic known as coronavirus disease-2019 (COVID-19), without exact cure up to date. The usage of immunosuppressi...

Full description

Bibliographic Details
Main Authors: Banu Çevik, Macit Ordu, Elif Bombacı, Sezer Yakupoğlu, Kemal Tolga Saraçoğlu
Format: Article
Language:English
Published: Galenos Yayinevi 2021-09-01
Series:Türk Yoğun Bakim Derneği Dergisi
Subjects:
Online Access: http://www.turkishjic.org/archives/archive-detail/article-preview/concurrent-management-of-a-patient-with-toxic-epid/47545
Description
Summary:Toxic epidermal necrolysis (TEN) is a serious cutaneous adverse reaction with high mortality rate. The severe acute respiratory syndrome-coronavirus-2 virus disease represented a global pandemic known as coronavirus disease-2019 (COVID-19), without exact cure up to date. The usage of immunosuppressive drugs during COVID-19 infection is a major clinical challenge; however, it seems inevitable in rare cases. Here we aimed to report a patient, who was treated concomitantly for TEN and COVID-19 with a good clinical outcome by reviewing the existing literature.
ISSN:2146-6416
2147-267X